TGFB1 and colorectal carcinoma: Our work supports the abovementioned findings and further demonstrates that TGF-β blockade could polarize the N2 pro-tumor phenotype of TANs towards N1 anti-tumor phenotype, which has a higher ability to destroy tumor cells in CRC.